Pathopharmacological Foundations for Advanced Nursing Practice – Asthma
This paper is for a MSN program. The course is Pathopharmacological Foundations for Advanced Nursing Practice. The subject is asthma. The paper needs to be written about Pathophysiology, pharmaceutical impact, managing care transitions,salience and care management.
- Investigated Disease Process (Introduction to paper)
- Tip: In section A, you will introduce your topic, including what is it and why you chose it.
- TIP: Section A1 should include pathophysiology of your selected disease topic from cellular changes to how the disease affects organs/body systems. Most of what you need should be in your eText McCance, K.L., Huether, S.E. (2014). Pathophysiology: The biologic basis for disease in adults and children (7th ed.). St. Louis, Missouri: Mosby Elsevier. ISBN: 978-0-323-08854-1
- TIP: Consider performing a Google search for the pathophysiology of the selected disease and choose images if you require a visual to provide you with greater understanding of the cascade of events at a cellular level.
A2. Standard of Practice
- Tip: Section A2 requires you to discuss the Standard of practice for your selected disease in detail. The Standard of practice is essentially the consensus of providers in a state or facility based on their daily routine management of a specific disease. Most Standards of practice align with the Clinical Practice Guidelines.
- Tip: You might locate the Standards of practice for your state using a Google search, or by locating the protocols at your specific institution.
- Tip: Clinical practice guidelines may help you to frame your discussion of Standards of practice and may be easily located via: http://www.guideline.gov
- Tip: Section A2a requires you to discuss the evidence-based pharmacological treatments used to manage the selected disease in your community. Consider using the Clinical practice guidelines and Standards of practice as guides.
- Tip: You might think about approaching a local provider or outpatient specialty clinic to inquire about the pharmacologic approaches they use and their successes and observations about patient response
- Tip: You might also think about performing a Google search on your county health department for information specific to the selected disease.
A2.a. Pharmacological Treatments
- Tip: What is unique about asthma medication management for transition of care to home?
- Tip: What consequences may result if plan is not completed?
A2b. Clinical Guidelines
- Tip: Section A2b focuses on a discussion of the clinical guidelines for your selected disease in the areas of assessment, diagnosis and patient education.
- Tip: Clinical Practice Guidelines are most likely the resource that provides you with needed information on those three elements.
A2c. Standard of Practice of Disease Management
- Tip: Section A2C focuses on a comparison of the standards of practice for managing the disease in your local community/organization with the state or national practices.
A3. Managed Disease Process
- Tip: Section A3 focuses on the managed disease process and the characteristics of, and resources for the patient who manages the disease effectively.
- Tip: Be sure to include information about how the patient with the disease would present, what quality of life they have, and what resources they need to manage their disease effectively.
- Tip: Discuss their access to care, treatment options, life expectancy, and outcomes when their disease is well-managed.
- Tip: Section A3a focuses on the disparities in management of the disease
- Tip: This section requires a discussion of the inconsistencies or differences in the management of the disease in the US (consider 2 regions, 2 states, 2 environments – such as rural vs urban, farming community vs industrial city).
- Tip: Following your discussion of two areas within the US, identify 2 nations outside the US and discuss their disparities in access to care, insurance, cultural impact, resources (consider selecting an industrialized nation and a developing nation and conduct a Google search
A4. Managed Disease Factors
A4a. Unmanaged Disease Factors
A4ai. Unmanaged Disease Characteristics
- Patients, Families, & Populations
- Best Practices Promotion
C1. Implementation Plan
C2. Evaluation Method
- Natio McCance, K.L., Huether, S.E. (2014). Pathophysiology: The biologic basis for disease in adults and children(7th). St. Louis, Missouri: Mosby Elsevier. ISBN: 978-0-323-08854-1
Frandsen, G. & Pennington, S.S. (2013). Abrams’ clinical drug therapy: Rationales for nursing practice. (10th ed). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins Print ISBN: 9781609137113, 1609137116